(Q88647826)

English

Nemolizumab in patients with moderate-to-severe atopic dermatitis: Randomized, phase II, long-term extension study

scientific article published on 10 May 2018

Statements

Nemolizumab in patients with moderate-to-severe atopic dermatitis: Randomized, phase II, long-term extension study (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit